Document is current
Any future updates will be listed below
-
Authors
Inagaki, Masahito
Abe, Naoko https://orcid.org/0000-0001-6062-3515
Li, Zhenmin
Nakashima, Yuko
Acharyya, Susit
Ogawa, Kazuya
Kawaguchi, Daisuke
Hiraoka, Haruka https://orcid.org/0000-0002-8022-6186
Banno, Ayaka
Meng, Zheyu
Tada, Mizuki
Ishida, Tatsuma
Lyu, Pingxue
Kokubo, Kengo
Murase, Hirotaka https://orcid.org/0000-0001-5747-191X
Hashiya, Fumitaka
Kimura, Yasuaki
Uchida, Satoshi https://orcid.org/0000-0001-8726-0478
Abe, Hiroshi https://orcid.org/0000-0003-0048-3789
-
Funding
Funding for this research was provided by:
MEXT | JST | Core Research for Evolutional Science and Technology (JPMJCR18S1)
Japan Agency for Medical Research and Development (JP21gm0010008)
- License Information
-
More Information
Article History
Received: 4 October 2022
Accepted: 21 April 2023
First Online: 11 May 2023
Competing interests
: H.A. and S.U. are cofounders of Crafton Biotechnology, and the company focuses on the development of mRNA therapeutics. An international patent application covering part of this work has been filed by JST and Nagoya University (inventor M.I., N.A., Z.L., Y.N., F.H., Y.K., H.A.; publication number WO/2023/282245). The remaining authors declare no competing interests.
